MedTrace Logo

A Pilot Feasibility Study of Fibroblast Calcium and Glucoregulation in Health and Disease

NCT01917669 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2016-10-25

No results posted yet for this study

Summary

The purpose of this research is to better understand how calcium and glucose may play a role in people developing diabetes. By doing this study, the investigator hopes to learn whether abnormal calcium and glucose responses in skin biopsies from healthy patients and patients with Type 2 diabetes can identify and predict patients at greatest risk for later complications.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Olivier Thibault, PhD · University of Kentucky

Eligibility

Min Age
40 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01917669 on ClinicalTrials.gov